Vaccines in adults. Why not?
DOI:
https://doi.org/10.19230/jonnpr.2128Keywords:
-Abstract
-Downloads
References
Immunization in immunocompromised host. En: Canadian Immunization Guide. National Advisory Committee on Immunization. Minister of Health. 6ª Ed. 2002.
Centers for Disease Control and Prevention.Guidelines for Preventing Opportunistic Infections Among Hematopoietic Stem Cell Transplant Recipients. MMWR 2000; 49 (RR-10):1-127.
Chin, J. Control of Communicable Diseases.American Public Health Association. J.Chin, editor. 17th Edition. 2000. (Publicación Científica y Técnica No.581).
Red Nacional de Vigilancia Epidemiológica.Centro Nacional de Epidemiología. Instituto de Salud Carlos III.
Gestal Otero JJ, Takkouche B, Blasco Huelva P. Infecciones respiratorias agudas. Gripe. En: Piedrola Gil. Medicina Preventiva y Salud Pública. Ed. Masson, 10ª Edición. 2001.
World Health Organization. Recommended composition of influenza virus vaccines for use in the 2003-2004 influenza season. Wkly Epidemiolo Rec. 2003; 9:58-62.
Musher, DM. Streptococcus pneumoniae. En: Mandell, Douglas, Bennett, editors. Principles and Practice of Infectious Diseases. Fourth edition. 1995. New York, Churchill Livingston Inc.
Fedson D, Musher D, Eskola J. Pneumococcal Vaccine. En: Plotkin S, Orenstein W, editors. Vaccines, 3th Ed. Philadelphia. WB Saunders.Co:1999; 553-608.
Butler JC, Breiman RF, Lipman HB, Broome CV, Facklam RR. Polysaccharide pneumococcal vaccine efficacy: an evaluation of current recommendations. JAMA 1993. 270: 1826-1831.
Ortqvist A, Hedlund J, Burman L, et al. Randomized trial of 23 valent pneumococcal capsular polysaccharide vaccine in prevention of pneumonia in middle-aged and elderly people. Lancet 1998. 351: 399- 403.
Moore RA, Wiffen PJ and Lipsky BA. Are pneumococcal polysaccharide vaccines effective? Meta-analysis of the prospective trials. BCM Family Practice 2000. 1(1). http://biomedcentral.com/1471-2296/1/1
Published
Issue
Section
License
All accepted originals remain the property of JONNPR. In the event of publication, the authors exclusively transfer their rights of reproduction, distribution, translation and public communication (by any sound, audiovisual or electronic medium or format) of their work. To do so, the authors shall sign a letter transferring these rights when sending the paper via the online manuscript management system.
The articles published in the journal are freely used under the terms of the Creative Commons BY NC SA license, therefore.
You are free to:
Share — copy and redistribute the material in any medium or format
Adapt — remix, transform, and build upon the material
The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
NonCommercial — You may not use the material for commercial purposes.
ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License
